Clinical trial
Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast…
NCT00128778 · Spanish Breast Cancer Research Group, Other · Completed
Key facts
| NCT number | NCT00128778 |
|---|---|
| Title | Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients |
| Official title | Phase IV.III Clinical Trial to Evaluate Maintenance Treatment With Caelyx vs. Observation After Administration of Induction Chemotherapy in Metastatic Breast Cancer Patients |
| Lead sponsor | Spanish Breast Cancer Research Group, Other |
| Collaborators | Schering-Plough Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Drug |
| Interventions | Pegylated liposomal doxorubicin |
| Enrollment | 288 |
| Start date | Oct 28, 2002 |
| Primary completion | Jun 1, 2007 |
| Completion | Jul 7, 2010 |
| First posted | Aug 10, 2005 |
| Last update posted | Mar 6, 2023 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: